Allianz Asset Management Gmb H Regeneron Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

  • $72.3 Billion
  • Q4 2024

A detailed history of Allianz Asset Management Gmb H transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 59,294 shares of REGN stock, worth $39.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
59,294
Previous 74,623 20.54%
Holding current value
$39.9 Million
Previous $78.4 Million 46.16%
% of portfolio
0.06%
Previous 0.11%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
SELL
$701.85 - $1046.91 $10.8 Million - $16 Million
-15,329 Reduced 20.54%
59,294 $42.2 Million
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $35.4 Million - $41.6 Million
-34,576 Reduced 31.66%
74,623 $78.4 Million
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $13 Million - $15.8 Million
-14,751 Reduced 11.9%
109,199 $115 Million
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $25.6 Million - $28.2 Million
-28,361 Reduced 18.62%
123,950 $119 Million
Q4 2023

Feb 12, 2024
SELL
$775.18 - $881.7 $4.87 Million - $5.54 Million
-6,282 Reduced 3.96%
152,311 $134 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $1.66 Million - $2.03 Million
2,400 Added 1.54%
158,593 $131 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $54.8 Million - $65 Million
-78,242 Reduced 33.37%
156,193 $112 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $35,385 - $43,002
-52 Reduced 0.02%
234,435 $193 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $12.9 Million - $14 Million
-18,241 Reduced 7.22%
234,487 $169 Million
Q3 2022

Nov 08, 2022
SELL
$573.97 - $724.32 $12.7 Million - $16 Million
-22,136 Reduced 8.05%
252,728 $174 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $8.09 Million - $10.9 Million
-14,757 Reduced 5.1%
274,864 $162 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $18.3 Million - $21.4 Million
30,707 Added 11.86%
289,621 $202 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $6.82 Million - $8.42 Million
12,549 Added 5.09%
258,914 $164 Million
Q3 2021

Nov 10, 2021
BUY
$574.03 - $680.96 $482,185 - $572,006
840 Added 0.34%
246,365 $149 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $50.1 Million - $59.1 Million
105,869 Added 75.81%
245,525 $137 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $12.6 Million - $15.4 Million
28,176 Added 25.27%
139,656 $66.1 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $3.26 Million - $4.14 Million
-6,811 Reduced 5.76%
111,480 $53.9 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $7.47 Million - $9.02 Million
-13,709 Reduced 10.39%
118,291 $66.2 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $9.2 Million - $12 Million
-18,648 Reduced 12.38%
132,000 $82.3 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $416,527 - $612,598
-1,239 Reduced 0.82%
150,648 $73.6 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $9.14 Million - $12.6 Million
33,344 Added 28.13%
151,887 $57 Million
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $2.16 Million - $2.52 Million
7,913 Added 7.15%
118,543 $32.9 Million
Q2 2019

Aug 08, 2019
SELL
$299.6 - $414.82 $1.76 Million - $2.43 Million
-5,858 Reduced 5.03%
110,630 $34.6 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $19.6 Million - $23.2 Million
52,759 Added 82.79%
116,488 $47.8 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $6.88 Million - $8.25 Million
20,478 Added 47.35%
63,729 $23.7 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $6.71 Million - $7.8 Million
-19,106 Reduced 30.64%
43,251 $17.5 Million
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $4.63 Million - $5.61 Million
-16,252 Reduced 20.67%
62,357 $21.5 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $39.9 Million - $49.7 Million
-126,293 Reduced 61.64%
78,609 $27.1 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $19.1 Million - $25 Million
53,292 Added 35.15%
204,902 $77 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $5.72 Million - $6.69 Million
13,265 Added 9.59%
151,610 $67.8 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-26,901 Reduced 16.28%
138,345 $69.3 Million
Q1 2017

Apr 17, 2019
BUY
N/A
28,603 Added 20.93%
165,246 $64 Million
Q4 2016

Apr 17, 2019
BUY
N/A
19,732 Added 16.88%
136,643 $50.2 Million
Q3 2016

Apr 17, 2019
BUY
N/A
116,911
116,911 $47.3 Million

Others Institutions Holding REGN

# of Institutions
1,485
Shares Held
84.8M
Call Options Held
1.51M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email